{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:13:14Z","timestamp":1792678394855,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.mayocp.2015.03.017","type":"journal-article","created":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T00:33:13Z","timestamp":1430872393000},"page":"791-800","source":"Crossref","is-referenced-by-count":209,"title":["The Cholangiopathies"],"prefix":"10.1016","volume":"90","author":[{"given":"Konstantinos N.","family":"Lazaridis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas F.","family":"LaRusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mayocp.2015.03.017_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0016-5085(86)90859-0","article-title":"Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents","volume":"90","author":"Yoon","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mayocp.2015.03.017_bib2","unstructured":"United Network for Organ Sharing website. http:\/\/www.unos.org. Accessed July 11,\u00a02014."},{"key":"10.1016\/j.mayocp.2015.03.017_bib3","unstructured":"UNOS Transplant Living website. http:\/\/www.transplantliving.org. July 11, 2014."},{"issue":"5","key":"10.1016\/j.mayocp.2015.03.017_bib4","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1053\/j.gastro.2004.08.006","article-title":"The cholangiopathies: disorders of biliary epithelia","volume":"127","author":"Lazaridis","year":"2004","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MOG.0b013e3280b079fb","article-title":"Cholangiocyte biology","volume":"23","author":"Bogert","year":"2007","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.03.017_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.gastro.2006.07.023","article-title":"Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver","volume":"132","author":"Alvaro","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2002-34501","article-title":"Functional heterogeneity of cholangiocytes","volume":"22","author":"Marzioni","year":"2002","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2015.03.017_bib8","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/hep.24590","article-title":"Multipotent stem\/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets","volume":"54","author":"Cardinale","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mayocp.2015.03.017_bib9","first-page":"186","article-title":"Biliary tree stem\/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages","volume":"220","author":"Carpino","year":"2012","journal-title":"J\u00a0Anat"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2012.10.011","article-title":"The dynamic biliary epithelia: molecules, pathways, and disease","volume":"58","author":"O'Hara","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00428-011-1048-3","article-title":"Ductal plates in hepatic ductular reactions: hypothesis and implications, I: types of ductular reaction reconsidered","volume":"458","author":"Desmet","year":"2011","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MOG.0000000000000051","article-title":"MicroRNAs and cholestatic liver diseases","volume":"30","author":"Marin","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.03.017_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cell.2014.02.012","article-title":"Individualized medicine from prewomb to tomb","volume":"157","author":"Topol","year":"2014","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.mayocp.2015.03.017_bib14","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-0034-1383726","article-title":"Environmental factors in primary biliary cirrhosis","volume":"34","author":"Juran","year":"2014","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2015.03.017_bib16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bpg.2011.10.005","article-title":"Diagnosis of primary biliary cirrhosis","volume":"25","author":"Hirschfield","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.03.017_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/apt.12581","article-title":"Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis","volume":"39","author":"Karlsen","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib19","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0168-8278(99)80097-X","article-title":"Familial primary biliary cirrhosis reassessed: a geographically-based population study","volume":"30","author":"Jones","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"24","key":"10.1016\/j.mayocp.2015.03.017_bib20","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.mayocp.2015.03.017_bib21","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ng.631","article-title":"Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis","volume":"42","author":"Hirschfield","year":"2010","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.mayocp.2015.03.017_bib22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ng.627","article-title":"Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis","volume":"42","author":"Liu","year":"2010","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.mayocp.2015.03.017_bib23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.789","article-title":"Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis","volume":"43","author":"Mells","year":"2011","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0034-1383729","article-title":"Breach of tolerance: primary biliary cirrhosis","volume":"34","author":"Wang","year":"2014","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2015.03.017_bib25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/hep.25691","article-title":"Up-regulation of microRNA 506 leads to decreased Cl-\/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis","volume":"56","author":"Banales","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mayocp.2015.03.017_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A\u00a0biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.mayocp.2015.03.017_bib27","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/ajg.2009.103","article-title":"Common genetic variation and haplotypes of the anion exchanger SLC4A2 in primary biliary cirrhosis","volume":"104","author":"Juran","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.03.017_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.03.017_bib29","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jhep.2009.09.015","article-title":"Ursodeoxycholic acid and primary biliary cirrhosis: EASL and AASLD guidelines","volume":"51","author":"Tsochatzis","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.mayocp.2015.03.017_bib30","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s00535-013-0903-1","article-title":"Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients","volume":"49","author":"Lammert","year":"2014","journal-title":"J\u00a0Gastroenterol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib31","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.mayocp.2015.03.017_bib32","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","article-title":"Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis","volume":"105","author":"Kumagi","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib33","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2015.03.017_bib34","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S2210-7401(12)70016-5","article-title":"Primary biliary cirrhosis and bile acids","volume":"36","author":"Corpechot","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"5","key":"10.1016\/j.mayocp.2015.03.017_bib35","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/hep.26018","article-title":"Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid","volume":"57","author":"Honda","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mayocp.2015.03.017_bib36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/liv.12290","article-title":"Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid","volume":"34","author":"Lens","year":"2014","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.mayocp.2015.03.017_bib37","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1600-6143.2010.03038.x","article-title":"Recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Silveira","year":"2010","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.mayocp.2015.03.017_bib38","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.mayocp.2015.03.017_bib39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","author":"Liermann Garcia","year":"2001","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mayocp.2015.03.017_bib40","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Neuberger","year":"2004","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.mayocp.2015.03.017_bib41","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib42","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management","volume":"145","author":"Eaton","year":"2013","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.mayocp.2015.03.017_bib43","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib44","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.mayocp.2015.03.017_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.728","article-title":"Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci","volume":"43","author":"Melum","year":"2011","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.mayocp.2015.03.017_bib46","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng.2616","article-title":"Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis","volume":"45","author":"Liu","year":"2013","journal-title":"Nat Genet"},{"issue":"47","key":"10.1016\/j.mayocp.2015.03.017_bib47","doi-asserted-by":"crossref","first-page":"19030","DOI":"10.1073\/pnas.1106408108","article-title":"Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype","volume":"108","author":"Rausch","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9301","key":"10.1016\/j.mayocp.2015.03.017_bib48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","article-title":"Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease","volume":"359","author":"Grant","year":"2002","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.mayocp.2015.03.017_bib49","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ncb1909","article-title":"Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion","volume":"11","author":"Rodier","year":"2009","journal-title":"Nat Cell Biol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.03.017_bib50","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/hep.26993","article-title":"Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis","volume":"59","author":"Tabibian","year":"2014","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.mayocp.2015.03.017_bib51","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. Ursodiol for primary sclerosing cholangitis","volume":"336","author":"Lindor","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib52","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mayocp.2015.03.017_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3748\/wjg.v18.i1.1","article-title":"Recurrence and rejection in liver transplantation for primary sclerosing cholangitis","volume":"18","author":"Fosby","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib54","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A\u00a0re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl"},{"issue":"19","key":"10.1016\/j.mayocp.2015.03.017_bib55","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib56","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MOG.0b013e3283298865","article-title":"Hepatobiliary disease in patients with cystic fibrosis","volume":"25","author":"Moyer","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.03.017_bib57","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jhep.2004.08.006","article-title":"Epidemiology of liver disease in cystic fibrosis: a longitudinal study","volume":"41","author":"Lamireau","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.mayocp.2015.03.017_bib58","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0168-8278(99)80299-2","article-title":"Liver involvement in cystic fibrosis","volume":"31","author":"Colombo","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.03.017_bib59","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0032-1329899","article-title":"Clues to the etiology of bile duct injury in biliary atresia","volume":"32","author":"Mack","year":"2012","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2015.03.017_bib60","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1750-1172-8-128","article-title":"Aetiology of biliary atresia: what is actually known?","volume":"8","author":"Petersen","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2015.03.017_bib61","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1053\/j.gastro.2010.07.042","article-title":"\u03b1-Enolase autoantibodies cross-reactive to viral proteins in a mouse model of biliary atresia","volume":"139","author":"Lu","year":"2010","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.mayocp.2015.03.017_bib62","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/hep.24807","article-title":"Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells","volume":"55","author":"Brindley","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.mayocp.2015.03.017_bib63","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2009.12.027","article-title":"Post-natal paucity of regulatory T cells and control of NK cell activation in experimental biliary atresia","volume":"52","author":"Miethke","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"14","key":"10.1016\/j.mayocp.2015.03.017_bib64","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1093\/hmg\/ddq196","article-title":"Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2","volume":"19","author":"Garcia-Barcelo","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.mayocp.2015.03.017_bib65","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00439-013-1368-2","article-title":"Replication of a GWAS signal in a Caucasian population implicates ADD3 in susceptibility to biliary atresia","volume":"133","author":"Tsai","year":"2014","journal-title":"Hum Genet"},{"issue":"5","key":"10.1016\/j.mayocp.2015.03.017_bib66","doi-asserted-by":"crossref","first-page":"e1209","DOI":"10.1542\/peds.2010-3495","article-title":"Stool color card screening for biliary atresia","volume":"128","author":"Tseng","year":"2011","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.mayocp.2015.03.017_bib67","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/hep.22182","article-title":"Universal screening for biliary atresia using an infant stool color card in Taiwan","volume":"47","author":"Hsiao","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib68","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MOG.0b013e328328f4ff","article-title":"Cholangiociliopathies: genetics, molecular mechanisms and potential therapies","volume":"25","author":"Masyuk","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.03.017_bib69","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/PAP.0b013e31815e5295","article-title":"Molecular basis of autosomal recessive polycystic kidney disease (ARPKD)","volume":"15","author":"Al-Bhalal","year":"2008","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.03.017_bib70","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hep.22636","article-title":"The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD)","volume":"49","author":"Banales","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mayocp.2015.03.017_bib71","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.gastro.2006.12.039","article-title":"Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate","volume":"132","author":"Masyuk","year":"2007","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.mayocp.2015.03.017_bib72","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1681\/ASN.2009121291","article-title":"Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease","volume":"21","author":"Hogan","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.mayocp.2015.03.017_bib73","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","article-title":"Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution","volume":"245","author":"DeOliveira","year":"2007","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.mayocp.2015.03.017_bib74","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jhep.2011.11.015","article-title":"Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?","volume":"56","author":"Khan","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.03.017_bib75","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1053\/j.gastro.2009.02.038","article-title":"Burden of digestive diseases in the United States, part III: liver, biliary tract, and pancreas","volume":"136","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.mayocp.2015.03.017_bib76","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cgh.2012.09.009","article-title":"Classification, diagnosis, and management of cholangiocarcinoma","volume":"11","author":"Razumilava","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.mayocp.2015.03.017_bib77","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1572-0241.2004.30281.x","article-title":"A\u00a0comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures","volume":"99","author":"Kipp","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"43","key":"10.1016\/j.mayocp.2015.03.017_bib78","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.3748\/wjg.v19.i43.7661","article-title":"Diagnosis of IgG4-related sclerosing cholangitis","volume":"19","author":"Nakazawa","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.03.017_bib79","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","volume":"143","author":"Darwish Murad","year":"2012","journal-title":"Gastroenterology"},{"issue":"14","key":"10.1016\/j.mayocp.2015.03.017_bib80","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619615002670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619615002670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T17:27:36Z","timestamp":1537637256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619615002670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0025619615002670"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2015.03.017","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}